BioNano Genomics, Inc. (NASDAQ:BNGO) has filed for up to 35,026,272 share offering by selling stockholders.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.
BNGO: A Bull or Bear Market Play?
Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks – 6 model portfolios fueled by AI stock picks with a stellar performance this year..
In 2024 alone, ProPicks' AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record.
With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies.
So if BNGO is on your watchlist, it could be very wise to know whether or not it made the ProPicks lists.